AN2 Therapeutics
ANTX
#8920
Rank
โ‚ฌ0.17 B
Marketcap
4,63ย โ‚ฌ
Share price
-2.68%
Change (1 day)
389.30%
Change (1 year)

EPS for AN2 Therapeutics (ANTX)

EPS in 2026 (TTM): -0,92ย โ‚ฌ

According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is -0,98ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,06ย โ‚ฌ an increase over its 2024 EPS that were of -1,57ย โ‚ฌ.

EPS history for AN2 Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,92ย โ‚ฌ-13.07%
2025-1,06ย โ‚ฌ-32.56%
2024-1,57ย โ‚ฌ-39.01%
2023-2,57ย โ‚ฌ-40.02%
2022-4,29ย โ‚ฌ